(Total Views: 440)
Posted On: 03/15/2019 4:10:40 PM
Post# of 109

$REGN News Article - Praluent (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease https://marketwirenews.com/news-releases/pral...50688.html


My Twitter: WhyteStocks